Thyroid function and chronic kidney disease in heart failure patients by Bivol, Elena
The 7th International Medical Congress for Students and Young Doctors 
 ____________________________________________________________________________________ 
 
45 
 
Key words: sleep apnea, cardiac pathologies, major cardiovascular events, arrhythmias, cardiac 
blocks 
 
45. THYROID FUNCTION AND CHRONIC KIDNEY DISEASE IN HEART FAILURE 
PATIENTS  
 
Author: Elena Bivol  
Scientific adviser: Liviu Grib, MD, PhD, Professor, Department of Internal Medicine, 
Cardiology 
Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova 
 
Introduction. In the last years, the global prevalence of the moderate-severe renal dysfunction 
has gradually increased to an epidemic state. The risk of chronic kidney disease occurrence in 
heart failure (HF) is not well established, but kidney dysfunction is very often encountered in HF 
patients and is associated with a poor prognosis. Thyroid hormone, also, has been identified as a 
risk factor for the heart disease progression and development. 
Aim of the study. To investigate whether thyroid function is associated with chronic kidney 
disease in heart failure patients. 
Materials and methods. This observational cohort study included 25 patients with reduced 
ejection fraction heart failure CKD. Routine biochemistry, including Cysteine C, thyroid 
stimulating hormone(TSH) and proteinuria were measured. Glomerular filtration rate (GFR) was 
estimated by the CKD-EPI CYSTETIN C based formula adjusted for Body Surface Area. We 
divided patients into two groups according to estimated GFR: ≥60ml/min (CKD stages I-II 
KDOQI); and <60ml/min(CKD stages III-V KDOQI). 
Results. Among 26 adult participants, 15 had moderate-to-severe decrease in eGFR<60 ml/min 
with a mean TSH level of 7.4±3.28 UN/ml(p<0.05); Cystetine C of 1.15±0.07 mg/L; mean 
ejection fraction (EF) of 43.4±2.84% level; uric acid level 446.2±81.27mmol/L; total cholesterol 
– 7.95±3.37 mmol/L; triglycerides 2.19 mmol/L and 0.12 g/l proteins in urine. 11 subjects had 
elevated, normal or mild decrease in eGFR≥60 ml/min; a mean TSH level of 2.2±0.65 UN/ml 
(p<0.01); Cystetine C of 1.74±0.13 mg/L; mean ejection fraction(EF) of 42±2.77%; uric acid 
level 235.5±113.5 mmol/L total cholesterol – 7.95±3.37 mmol/L; triglycerides 2.19 mmol/L, and 
0.07 g/l proteins in urine. Compared with participants with an estimated GFR ≥60 ml/min, those 
with estimated GFR <60 ml/min had an increased rate of subclinical primary hypothyroidism, 
higher levels of uric acid, total cholesterol and triglycerides. 
Conclusions. Our results suggest that subclinical hypothyroidism is associated not only with 
heart failure but also with CKD, and may be considered as a novel risk factor of reduced renal 
function. Further studies are needed to better understand the causal implications of 
hypothyroidism in CKD patients.  
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Introduction. Statins are a class of lipid-lowering medications, also known as HMG-CoA 
reductase inhibitors. They are considered one of the most popular prescribed agents worldwide 
for treatment of hypercholesterolemia. Statins are effective drugs to reduce cardiovascular events 
